AR and neoplasm: In our previous work with heterogeneous CRPC tumors and cell lines, we showed that high-level AR-V expression, either concurrent with or exclusive from full-length AR, can often be ascribed to sub-clonal populations of tumor cells harboring underlying AR gene rearrangements (15–17).